GEN-06 CLINICAL COURSE AFTER TUMOR RECURRENCE OF MGMT HYPERMETHYLATED GLIOBLASTOMA

MGMT methylation in glioblastoma is a biomarker for determining treatment responsiveness and predicting prognosis. We analyzed whether there were differences in the prognosis between glioblastoma with MGMT hypermethylation and other glioblastomas after tumor recurrence. We enrolled 184 patients who...

Descripción completa

Detalles Bibliográficos
Autores principales: Adachi, Junichi, Shirahata, Mitsuaki, Suzuki, Tomonari, Mishima, Kazuhiko, Fujimaki, Takamitsu, Nishikawa, Ryo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213324/
http://dx.doi.org/10.1093/noajnl/vdz039.035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213324/
http://dx.doi.org/10.1093/noajnl/vdz039.035

Ejemplares similares